Article
CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation.
The Prostate - 1 Sept 2022
Hua Xiaoliang, Zhang Jiong, Ge Shengdong, Liu Haoran, Du Hexi, Niu Qingsong, Chen Xianguo, Yang Cheng, Zhang Li, Liang Chaozhao
Abstract excerpt
BACKGROUND: Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) is an inflammatory immune disease that is characterized by infiltrating inflammatory cells in the prostate and pelvic or by perineal pain. Receptor CXCR3modulates immune and inflammatory responses; however, the effects of CXCR3 antagonist AMG487 in the context of CP/CPPS are unknown. Therefore, we investigated the effect of AMG487 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
